Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Brain InjuriesHead Injury
Interventions
DIAGNOSTIC_TEST

Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT

"The i-STAT TBI cartridge is a point-of-care, whole-blood, biomarker-based assay that measures the level of biomarkers associated with brain injury in the bloodstream 24 hours after injury. Blood samples (5-10cc of whole blood) will be collected upon admission during a routine blood draw in the ED. These samples will be tested using the iSTAT system for mild TBI biomarkers.~In a subset of admitted patients, serial blood draws and iSTAT testing will be performed at 4, 8, 16, and 24 hours, depending on the patient's length of stay."

Trial Locations (1)

30303

RECRUITING

Grady Health System, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Emory University

OTHER